821 related articles for article (PubMed ID: 32768398)
1. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics.
Tan YY; Yap PK; Xin Lim GL; Mehta M; Chan Y; Ng SW; Kapoor DN; Negi P; Anand K; Singh SK; Jha NK; Lim LC; Madheswaran T; Satija S; Gupta G; Dua K; Chellappan DK
Chem Biol Interact; 2020 Sep; 329():109221. PubMed ID: 32768398
[TBL] [Abstract][Full Text] [Related]
2. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
[TBL] [Abstract][Full Text] [Related]
3. Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics.
Ang MJY; Chan SY; Goh YY; Luo Z; Lau JW; Liu X
Adv Drug Deliv Rev; 2021 Nov; 178():113907. PubMed ID: 34371084
[TBL] [Abstract][Full Text] [Related]
4. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
[TBL] [Abstract][Full Text] [Related]
5. Engineered Polymer-Based Nanomaterials for Diagnostic, Therapeutic and Theranostic Applications.
Parisi OI; Scrivano L; Sinicropi MS; Picci N; Puoci F
Mini Rev Med Chem; 2016; 16(9):754-61. PubMed ID: 26156541
[TBL] [Abstract][Full Text] [Related]
6. An insight into the dual role of MoS2-based nanocarriers in anticancer drug delivery and therapy.
Ghosh S; Lai JY
Acta Biomater; 2024 Apr; 179():36-60. PubMed ID: 38552760
[TBL] [Abstract][Full Text] [Related]
7. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.
Chakraborty S; Dhakshinamurthy GS; Misra SK
J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475
[TBL] [Abstract][Full Text] [Related]
8. Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application.
Rizwanullah M; Ahmad MZ; Garg A; Ahmad J
Biochim Biophys Acta Gen Subj; 2021 Sep; 1865(9):129936. PubMed ID: 34058266
[TBL] [Abstract][Full Text] [Related]
9. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
Kundu P; Singh D; Singh A; Sahoo SK
Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
[TBL] [Abstract][Full Text] [Related]
10. Multicolorful Carbon Dots for Tumor Theranostics.
Wang H; Bi J; Zhu BW; Tan M
Curr Med Chem; 2018; 25(25):2894-2909. PubMed ID: 28302015
[TBL] [Abstract][Full Text] [Related]
11. Copper chalcogenide materials as photothermal agents for cancer treatment.
Liu K; Liu K; Liu J; Ren Q; Zhao Z; Wu X; Li D; Yuan F; Ye K; Li B
Nanoscale; 2020 Feb; 12(5):2902-2913. PubMed ID: 31967164
[TBL] [Abstract][Full Text] [Related]
12. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
[TBL] [Abstract][Full Text] [Related]
13. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
Raj R; Mongia P; Kumar Sahu S; Ram A
Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
[TBL] [Abstract][Full Text] [Related]
14. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.
Fernandez-Fernandez A; Manchanda R; McGoron AJ
Appl Biochem Biotechnol; 2011 Dec; 165(7-8):1628-51. PubMed ID: 21947761
[TBL] [Abstract][Full Text] [Related]
15. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
16. Application and Future Prospect of Extracellular Matrix Targeted Nanomaterials in Tumor Theranostics.
Fang W; Su D; Lu W; Wang N; Mao R; Chen Y; Ge K; Shen A; Hu R
Curr Drug Targets; 2021; 22(8):913-921. PubMed ID: 33504304
[TBL] [Abstract][Full Text] [Related]
17. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
[TBL] [Abstract][Full Text] [Related]
18. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
19. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
Tripathi P; Shukla P; Bieberich E
Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
[TBL] [Abstract][Full Text] [Related]
20. Advances in Nanocarriers for Anticancer Drugs Delivery.
Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
